Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01)
Crossref DOI link: https://doi.org/10.1245/s10434-016-5132-4
Published Online: 2016-02-09
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kasper, Bernd
Gruenwald, Viktor
Reichardt, Peter
Bauer, Sebastian
Hohenberger, Peter
Haller, Florian
Text and Data Mining valid from 2016-02-09